SP
Starpharma Holdings Limited
SPHRY · OTC
$5.22 -0.38% (-$0.02)
1M +7.41%
Market Cap $308.8M
P/E Ratio -
Div. Yield 1.29%
ROE 37.73%
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/S 26.20x
P/B 22.42x
P/E N/A
Growth
78 /100
Growing Rev. growth 39.49%
Book val. growth 26.58%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 86.26%
Net margin 61.95%
Op. margin 159.60%
Quality
8 /100
Poor ROIC 51.82%
ROE 37.73%
ROA 38.39%
Debt
100 /100
Low Debt/Equity 0.05x
Current ratio 3.40x
Int. coverage N/A
Stability
43 /100
Moderate Beta 0.77x
Rev. volatility 72.71%
EPS volatility 34.85%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SPHRY
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Cheryl Maley
Employees
50
Headquarters
Abbotsford
Prihajajoči dogodki
02 MAR.
Earnings
Upcoming earnings report